Two columns: expected, and override
On a protocol, every marker falls into one of two columns. Expected shifts are the monitored consequences of the dials you set — they are not problems. Override flags are the hard lines that mean act, regardless of how good everything else looks. Reading enhanced bloodwork is the discipline of sorting each value into the right column, and never letting a good number in one place excuse a dangerous number in another.
What's expected — and not a problem
These shifts are the feedback loop and the pharmacology working as designed:
- LH and FSH suppressed to near zero on any exogenous androgen — expected feedback, not secondary hypogonadism.
- Total and free testosterone above the natural band — expected; read the trough and symptoms, not a peak.
- SHBG falling, especially on orals — expected; it raises free testosterone.
- Estradiol rising roughly with dose and body fat — expected and protective; the goal is management, not eradication.
- Hematocrit and hemoglobin climbing — expected from stimulated red-cell production (the dial), until they cross the line below.
- IGF-1 climbing on GH-secretagogue protocols — expected; that's the point.
- Fasting glucose and insulin drifting up on GH-class protocols — expected, because growth hormone opposes insulin.
- Lipids shifting on oral compounds — HDL down, LDL/ApoB up, within weeks — expected on orals.
None of these, alone, is a reason to stop. They are the dials, read where you set them.
The override flags — hard lines, no matter how good you feel
- Hematocrit crossing the guideline threshold (~54%). This is the firmest line in enhancement. The major endocrine guideline defines testosterone-induced erythrocytosis at a hematocrit above 54% and calls for withholding therapy until it normalizes, then resuming at a lower dose. Many clinicians begin watching closely around 52% — sensible practice, though the named guideline line is 54%. Read it on a hydrated draw, because dehydration alone inflates it. (The next-but-one chapter covers this marker in full.)
- Sustained high ApoB / collapsed HDL that doesn't recover off cycle — the real cardiovascular cost of orals, not an acceptable price.
- Climbing liver enzymes with a rising GGT or bilirubin, or any liver symptoms — genuine hepatobiliary damage, not muscle enzyme leak.
- Genuine eGFR decline confirmed on cystatin C — not the creatinine/muscle artifact, the real thing.
- Symptomatic estradiol at either extreme, or sexual dysfunction on 19-nor compounds.
- Fasting insulin and HOMA-IR climbing on GH-class protocols — the metabolic cost of pushing the GH axis.
The cardinal error
A good number never buys back a dangerous one. A textbook testosterone with a hematocrit of 56% is not a win; it is a hematocrit of 56%. The athletes who get hurt are almost never the ones whose whole panel went bad at once — they are the ones who let one excellent marker talk them past a single hard line. Sort every value into expected or override, act on the override column, and let the expected column be exactly what it is: the dials, doing what you set them to do.
Educational content, not individual medical advice.